Back to today’s briefing

Story perspectives

FDA Resignation Sparks Controversy as Marks Joins Eli Lilly

10/8/2025

44 7

Summary

Story summary

Peter Marks has joined Eli Lilly as senior vice president for molecule discovery and head of infectious diseases.
The appointment follows a controversial FDA resignation amid disputes with Health Secretary Robert F. Kennedy Jr.
The move mirrors a broader trend of FDA officials joining industry and raises concerns about regulatory integrity, with other departures to Lilly and Pfizer.

1 of 1

Story summary

Peter Marks has joined Eli Lilly as senior vice president for molecule discovery and head of infectious diseases.
The appointment follows a controversial FDA resignation amid disputes with Health Secretary Robert F. Kennedy Jr.
The move mirrors a broader trend of FDA officials joining industry and raises concerns about regulatory integrity, with other departures to Lilly and Pfizer.